Literature DB >> 1756538

Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.

R N Damle1, S H Advani, S G Gangal.   

Abstract

In this paper, we have correlated the ability of peripheral blood lymphocytes (PBL) from Hodgkin's Disease patients to proliferate in response to a mitogen, phytohaemagglutinin (PHA), with production of lymphokines interleukin-2 (IL-2) and interferon gamma (IFN gamma), accumulating in the activated lymphocyte culture supernatants. We have also studied the frequency distribution of PHA-responsive and IL-2-producing T cells from PBL using limiting-dilution analysis. We observed that the levels of IL-2 and IFN gamma in the supernatants of activated lymphocytes from patients with Hodgkin's disease were significantly reduced compared to those of healthy donors. Substage-B patients showed marked reduction in the ability to produce IFN gamma. Levels of IL-2 and IFN gamma in the culture supernatants of PBL from Hodgkin's disease patients correlated positively with proliferative responses, when analysed by linear regression (r = 0.79 and r = 0.60 respectively). However, production of the two lymphokines by activated lymphocytes from the same patients did not correlate (r = +0.04). Further, the frequencies of PHA-responsive cells and IL-2-producing cells in the PBL of patients with Hodgkin's disease (ranges 1/111-1/554 and 1/3009-1/6709 respectively) were also less than those of the healthy donors (ranges 1/80-1/181 and 1/761-1/1828 respectively). Proliferation, IL-2 production in bulk cultures and frequencies of PHA-responsive and IL-2-producing cells correlated well in individual healthy donors. Whereas, one patient (BC 11,214) with a frequency of PHA-responsive cells within normal limits had a very low frequency of IL-2-producing cells. Taken together, the results indicate abnormalities in cytokine production and frequency distribution of cells required for amplification of immune response in patients with Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756538     DOI: 10.1007/bf01742314

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  29 in total

1.  Production of interleukin-2 and expression of tac antigen in Hodgkin disease.

Authors:  N N Joshi; R Mukhopadhyay; S H Advani; S G Gangal
Journal:  Cancer Detect Prev Suppl       Date:  1987

2.  Independent regulation of IFN-gamma and tumor necrosis factor by IL-1 in human T helper cells.

Authors:  H Fischer; G Hedlund; T Kalland; H O Sjögren; M Dohlsten
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  An improved colorimetric assay for T cell cytotoxicity in vitro.

Authors:  A Müllbacher; C R Parish; J P Mundy
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

6.  Demonstration of inhibitory factors affecting cell-mediated immunity in patients with Hodgkin's disease.

Authors:  M V Moghe; S H Advani; S G Gangal
Journal:  Eur J Cancer       Date:  1980-07       Impact factor: 9.162

7.  Interleukin-2 induction of T-cell G1 progression and c-myb expression.

Authors:  J B Stern; K A Smith
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

8.  Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease.

Authors:  R Mukhopadhyaya; S H Advani; S G Gangal
Journal:  Cancer Detect Prev       Date:  1987

9.  Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.

Authors:  R I Fisher
Journal:  Cancer Treat Rep       Date:  1982-04

10.  Sequential expression of genes involved in human T lymphocyte growth and differentiation.

Authors:  M Krönke; W J Leonard; J M Depper; W C Greene
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.

Authors:  Jodi Chiu; Daniel M Ernst; Armand Keating
Journal:  Front Immunol       Date:  2018-02-14       Impact factor: 7.561

Review 3.  Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.

Authors:  Eleonora Calabretta; Francesco d'Amore; Carmelo Carlo-Stella
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.